Pat Beyer
President and Chief Executive Officer
Replay available
CONMED Corporation (NYSE: CNMD) Q4 2025 earnings conference call, held 2026-01-28. Replay captured from the company's public earnings webcast.

President and Chief Executive Officer
Analyst, Jefferies
Analyst, Needham & Company
Executive Vice President and Chief Financial Officer
Analyst, Piper Sandler
Analyst, Bank of America
Analyst, JPMorgan
Analyst, Wells Fargo
After the speaker's presentation, there will be a question and answer session. To ask a question during the session, you'll need to press star 1 1 on your telephone. You will then hear an automated message advising your hand is raised. To withdraw your question, please press star 1 1 again. Please be advised that today's conference is being recorded. Before the conference call begins, let me remind you that during this call, management will be making comments and statements regarding its financial outlook, its plans and objectives. These statements represent the forward-looking statements that involve risk and uncertainties as those terms are defined under the federal securities laws. Investors are cautioned that any such forward-looking statements that are not guarantees of future events, performance, or results, the company's actual results may differ materially from its current expectations. Please refer to the risk and other uncertainties disclosed under the forward-looking information in today's press release. as well as the company's SEC filings for more details on the risk and uncertainties that may cause actual results to differ materially. The company disclaims any obligation to update any forward-looking statements that may be discussed during the call, except as may be required by applicable law. You will also hear management refer to non-GAAP or adjusted measurements during this discussion. While these figures are not a substitute for GAAP measurements, Management uses these figures to aid in monitoring the company's ongoing financial performance from quarter to quarter and year to year on a regular basis and for benchmarking against other medical technology companies. Adjusted net income and adjusted earnings per share measure the income of the company e...